EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:755270 - durvalumab
| ChEBI ID | CHEBI:755270 |
| ChEBI Name | durvalumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Role: | anti-HBV agent An antiviral agent that destroys or inhibits the replication of the hepatitis B virus. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antifibrotic agent Any agent which acts to reduce fibrosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| durvalumab (CHEBI:755270) has role anti-HBV agent (CHEBI:64951) |
| durvalumab (CHEBI:755270) has role antifibrotic agent (CHEBI:233423) |
| durvalumab (CHEBI:755270) has role antineoplastic agent (CHEBI:35610) |
| durvalumab (CHEBI:755270) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Durvalumab | ChEMBL |
| MEDI-4736 | ChEMBL |
| MEDI4736 | ChEMBL |
| Brand Name | Source |
|---|---|
| Imfinzi | ChEMBL |